MLH1 and cancer: Borden et al., recently reported that hMLH1 hypermethylation in EC had a strong association with higher recurrence rates and worse prognosis; hMLH1 promoter hypermethylation in individuals was more likely to recur, even in patients accompanied by low-grade, early-stage cancer [99].